Pulmonary Hypertension Clinical Trial
Official title:
Assessment of Exercise Capacity and Standardization of Six Minute Walk Test in Patients With Pulmonary Hypertension
The 6 minute walk (6MW) gives information about the exercise capacity and it is an important
tool for clinical decisions and for the prognostic evaluation of PH patients. The test is
technically simple to perform, inexpensive and reproducible. During the 6MW O2 saturation,
heart rate, walking distance (in this study after every minute) and the level of dyspnea
(BORG-dyspnea scale) may be recorded; however, at present, mainly the walking distance is
evaluated. The test is sometimes criticized, because of the dependence on the patient's
motivation.
The purpose of the present study is to standardize the test by the incorporation of
objective factors. The investigators are correlating the change of heart rate and dyspnea
(BORG scale) with the achieved walking distance during subsequent examinations performed
with different effort.
On two different days the patients have to absolve four 6MW on different levels of effort -
on both days a traditional test will be performed and additionally a test with more effort
or with less effort. The order of the tests will be randomized. These two days of the
examinations should be within a maximum of three months, provided that there is no sign of
relevant clinical changes. After every minute the walking distance is determined. Heart rate
and the O2 saturation are measured by pulsoxymetry during the whole test. Every two minutes
the patients are asked about their dyspnea (Borg scale).
The purpose of the present study is to standardize the test by the incorporation of
objective factors and to detect the correlation between the walking distance and the level
of effort during exercise. The investigators expect that the reliability and objectivity of
6MW may increase by the standardization.
The additionally performed cardiopulmonary exercise testing helps to evaluate and stratify
patients.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01950585 -
Hydroxyurea in Pulmonary Arterial Hypertension
|
Early Phase 1 | |
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Completed |
NCT03649932 -
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
|
Phase 1 | |
Recruiting |
NCT04554160 -
Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring
|
||
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT01894035 -
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
|
||
Not yet recruiting |
NCT04083729 -
Persistent Pulmonary Hypertension After Percutaneous Mitral Commissurotomy
|
N/A | |
Completed |
NCT02216279 -
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
|
Phase 2 | |
Completed |
NCT02821156 -
Study on the Use of Inhaled NO (iNO)
|
N/A | |
Terminated |
NCT02243111 -
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
|
N/A | |
Terminated |
NCT02246348 -
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
|
N/A | |
Recruiting |
NCT01913847 -
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
|
Phase 3 | |
Completed |
NCT06240871 -
Contrast Enhanced PA Pressure Measurements
|
||
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT02377934 -
Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study
|
||
Recruiting |
NCT01091012 -
Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
|
Phase 3 | |
Completed |
NCT01484899 -
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
|
N/A | |
Completed |
NCT01463514 -
Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension
|
N/A | |
Completed |
NCT00739375 -
The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.
|
Phase 1 | |
Completed |
NCT02275793 -
The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
|